![Photo of Professor Andrew Carnell](https://pcwww.liv.ac.uk/~acarnell/Anderw%20Carnell/AJC_files/Photo%209.png)
Professor Andrew Carnell BSc PhD
Professor Chemistry
- +44 (0)151 794 1304 / +44 (0)151 794 3531
- Work email A.J.Carnell@liverpool.ac.uk
- Personal WebsiteCarnell Group website
- About
- Research
- Publications
- Teaching
- Professional Activities
Research
Research Group Membership
Research Grants
Development of oxidases for synthesis of bioplastics intermediates
BIOTECHNOLOGY & BIOLOGICAL SCIENCE RESEARCH COUNCIL
March 2021 - May 2023
Remote functionalisation of cyclic ketones using cascade biocatalysis reactions
BIOCATNET (UK)
August 2018 - January 2019
Enzymatic methylation of bio-derived aromatic diacids as bioplastics precursors
BIOCATNET (UK)
November 2017 - June 2018
Synthetic biology approaches to natural sunscreens
BIOTECHNOLOGY & BIOLOGICAL SCIENCE RESEARCH COUNCIL, UNILEVER PLC (UK)
March 2017 - September 2017
Scale-up and commercial evaluation of the manufacture of bio-based FDCA from HMF
INNOVATE UK (UK)
October 2017 - September 2019
Genome Mining for Bacterial Aldehyde Oxidases
BIOTECHNOLOGY & BIOLOGICAL SCIENCE RESEARCH COUNCIL
August 2015 - February 2016
Evaluation of the technical and commercial feasibility of the manufacture of bio-based polyester from cellulose derived hydroxymethyl furfural
BIOTECHNOLOGY & BIOLOGICAL SCIENCE RESEARCH COUNCIL
June 2015 - May 2016
Small items of Research Equipment at the University of Liverpool
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
November 2012 - March 2013
Development of an enzyme-catalysed desymmetrization of prochiral ketones.
BIOTECHNOLOGY & BIOLOGICAL SCIENCE RESEARCH COUNCIL
July 1998 - July 2001
Cloning and characterisation of enzymes required for the in vitro synthesis of the antimalarial artemisinin.
MEDICAL RESEARCH COUNCIL
September 2002 - August 2003
CASE Studentship: Inhibitors for new protein targets in cancer, cystic fibrosis and neurodegenerative diseases
MICROCAL (UK)
August 2009 - July 2013
Inhibition of a-methylacyl CoA racemase (AMACR1A): a potential therapy for prostate cancer.
NORTH WEST CANCER RESEARCH FUND
August 2009 - July 2013
Research Collaborations
Dr Igor Barsukov
Internal
Co applicant on BBRSC grant re talin biology
Prof Lu-Yun Lian
Internal
Characterisation and inhibition of α-methylacylCoA racemase
(AMACR1A): a potential therapeutic target for prostate cancer. Grant from NWCRF 198K, PDRA 2009-2012.
Professor William Isaacs
External: John Hopkins University
Testing biologicallly active compounds
Sacha Ferdinandusse
External: University of Amsterdam
enzyme inhibitions studies